Nykaa share value: Scorching Shares: Brokerage on Tech Mahindra, Solar Pharma, and Nykaa

International brokerage agency Macquarie maintained an outperform ranking on , Morgan Stanley retained an obese ranking on and BofA upgraded to a purchase.

We’ve collated a listing of suggestions from prime brokerage companies from ETNow and different sources:


Macquarie on Tech Mahindra: Outperform | Goal Rs 1230


Macquarie maintained an outperform ranking on Tech Mahindra with a goal value of Rs 1230.

One other brokerage agency BofA maintained a purchase name on Tech Mahindra with a goal of Rs 1180. Deal closures want watching within the forthcoming quarters, the brokerage stated.

Margins had been largely in-line in Q2. Working leverage stays key for an uptick in H2, it added.

Morgan Stanley on Solar Pharma: Chubby | Goal Rs 1150

Morgan Stanley maintained an obese ranking on Solar Pharma with a goal value of Rs 1150. It reported a powerful Q2FY23, the brokerage stated.

BofA on Nykaa: Purchase| Goal Rs 1555

BofA upgraded Nykaa to purchase with a goal value of Rs 1555. The corporate is properly positioned to maintain income progress and margin enchancment, BofA stated.

The corporate reported a powerful EBITDA beat. The inventory has underperformed not too long ago, however the firm has strong fundamentals, and best-in-class execution, the brokerage added.

(Disclaimer: Suggestions, ideas, views and opinions given by the specialists are their very own. These don’t characterize the views of Financial Instances)